Easy access to glaucoma care through an innovative portable, fast and easy-to-use Virtual Reality headset supported by visual field testing software to measure glaucoma progression.
PeriVision has raised €4.1M across 2 funding rounds from 12 investors, most recently a Seed round in Sep 2025. Based in Bern, Switzerland; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-09-12 | Seed | €2.6M | Arya VC ,CADFEM,DART Ventures,InaTec,Is Bank’s AI Factory,Juchum Foundation+5 more | View deal → |
| 2021-12-21 | Other | €1.5M | EIT Health | View deal → |
